GWW vs NRIX · P/E 27, rev $9.76B vs rev $15.3M
WW Grainger Inc (GWW) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the GWW and NRIX stock pages for the full models.
Not investment advice.